Resveratrol 500 mg oral once daily.

DIETARY_SUPPLEMENT2 trials

Sponsors

University at Buffalo, Texas Tech University

Conditions

Anabolic ResistanceInsulin ResistanceObesitySarcopeniaType 2 Diabetes

Unknown Phase

Resveratrol in Type2 Diabetes and Obesity

TerminatedNCT01158417

University at BuffaloInsulin Resistance, Obesity, Type 2 Diabetes

Start: 2008-12-31End: 2012-07-08Updated: 2022-11-09

Strength Training and Resveratrol

RecruitingNCT06585865

Texas Tech UniversityAnabolic Resistance, Sarcopenia

Start: 2025-06-13End: 2027-08-01Target: 36Updated: 2026-07-07